CartiNova, a regenerative medicine clinic focused on orthopedic and spine care, has launched in Atlanta. Founded by Trevor Turner, MD, a regenerative orthopedics physician, the practice offers minimally invasive, in-office procedures for knee and spine conditions as an alternative to…
Biologics
Regenerative medicine now sits in a complicated place in orthopedic care. Patients ask about it routinely. Clinics promote it aggressively. Stories of injections replacing surgery circulate widely online. Platelet-rich plasma and stem cell-based therapies have become part of the orthopedic…
Orthofix introduced its Biologics Surgeon Advisory Board which includes seven spine surgeons, according to a Feb. 4 news release. The board includes experts in orthopedic spine and spinal neurosurgery, and they were chosen based on their clinical experience, leadership in…
NanoFuse bioactive glass–demineralized bone matrix composite was found to be stronger than DBM alone or bioactive glass alone, according to a study in the International Journal of Spine Surgery. Researchers examined whether combining DBM and bioactive glass could produce a…
Kolosis Bio and nonprofit MTF Biologics are launching Summit Matrix, a synthetic bone graft for spine and orthopedic surgeries. The bone graft is supported by NanoLift surface technology and designed to improve bone regeneration, according to a Jan. 14 news…
Advertisement
Tetrous earned a U.S. patent related to its EnFix family of demineralized cortical bone fiber implants, according to a Jan. 13 news release. The new patent protects the application of EnFix DBF technology for enthesis reformation. The platform leverages a…
Tammam Hanna, MD, an orthopedic surgeon in Lubbock, Texas, performed the first U.S. clinical case of TYBR Health’s B3 Gel system, according to a Jan. 5 news release. B3 Gel is a collagen-based tissue protector derived from extracellular matrix and…
Here are four updates in spine and orthopedic biologics since Nov. 6. 1. Xtant Medical’s CollagenX wound healing product is out in a full commercial launch. CollagenX can be used by cases that Xtant Medical’s spine and orthopedics biologics portfolio…
A 24-month study of Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft found it had better time-to-fusion and clinical success than a local autograft, according to a Dec. 17 news release. Five things to know: 1. The controlled IDE study included…
Xtant Medical released its nanOss Strata synthetic bone graft in a commercial launch, according to a Dec. 11 news release. The bone graft is manufactured from hydroxycarbonapatite, which is more soluble than traditional hydroxyapatite. The bone graft is designed to…